- The AROMHA Brain Health Test (ABHT) is a digital remote olfactory assessment developed by researchers at Massachusetts General Hospital.
- It can differentiate between cognitively normal older adults and those with mild cognitive impairment.
- Olfactory performance is associated with Alzheimer's disease biomarkers, making olfactory testing a potential early screening approach.
- The test components include odor percept identification, odor episodic memory, odor discrimination, and a metacognition measure.
- The ABHT has potential applications in efficient screening for clinical trials targeting preclinical or early-stage disease and in exploring the utility of olfactory biomarkers to predict neurodegenerative diseases.
Source: Scientific Reports
